Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene
- PMID: 12705905
- DOI: 10.1016/s0006-291x(03)00551-5
Guggulsterone antagonizes farnesoid X receptor induction of bile salt export pump but activates pregnane X receptor to inhibit cholesterol 7alpha-hydroxylase gene
Abstract
Bile acids activate a nuclear receptor, farnesoid X receptor (FXR), that induces bile salt export pump (BSEP) but inhibits cholesterol 7alpha-hydroxylase (CYP7A1) gene transcription in the liver. Guggulsterone, a plant sterol that lowers serum cholesterol, has been shown to antagonize FXR activated genes. Transient transfection assay of a human BSEP/luciferase reporter in HepG2 cells transfected with FXR reveals that guggulsterone strongly antagonizes bile acid induction of the BSEP gene. On the other hand, guggulsterone has no effect on FXR inhibition of the CYP7A1 gene, but strongly inhibits the human CYP7A1 gene by activation of pregnane X receptor (PXR). These results suggest that guggulsterone inhibits bile acid secretion from hepatocytes into bile and activates PXR to inhibit bile acid synthesis in the liver. Reduced conversion of cholesterol and bile acid excretion may lead to an increase of hepatic cholesterol and decrease of intestinal cholesterol absorption, and results in lowering serum cholesterol.
Similar articles
-
Guggulsterone is a farnesoid X receptor antagonist in coactivator association assays but acts to enhance transcription of bile salt export pump.J Biol Chem. 2003 Mar 21;278(12):10214-20. doi: 10.1074/jbc.M209323200. Epub 2003 Jan 13. J Biol Chem. 2003. PMID: 12525500
-
The hypolipidemic agent guggulsterone regulates the expression of human bile salt export pump: dominance of transactivation over farsenoid X receptor-mediated antagonism.J Pharmacol Exp Ther. 2007 Mar;320(3):1153-62. doi: 10.1124/jpet.106.113837. Epub 2006 Nov 29. J Pharmacol Exp Ther. 2007. PMID: 17135343 Free PMC article.
-
Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: molecular modeling with biological evaluation.Steroids. 2013 Sep;78(9):813-22. doi: 10.1016/j.steroids.2013.04.018. Epub 2013 May 23. Steroids. 2013. PMID: 23707573
-
Bile salt excretory pump: biology and pathobiology.J Pediatr Gastroenterol Nutr. 2006 Jul;43 Suppl 1:S10-6. doi: 10.1097/01.mpg.0000226385.71859.5f. J Pediatr Gastroenterol Nutr. 2006. PMID: 16819395 Review.
-
Therapeutic effects of guggul and its constituent guggulsterone: cardiovascular benefits.Cardiovasc Drug Rev. 2007 Winter;25(4):375-90. doi: 10.1111/j.1527-3466.2007.00023.x. Cardiovasc Drug Rev. 2007. PMID: 18078436 Review.
Cited by
-
Potential therapeutic targets of Guggulsterone in cancer.Nutr Metab (Lond). 2017 Feb 28;14:23. doi: 10.1186/s12986-017-0180-8. eCollection 2017. Nutr Metab (Lond). 2017. PMID: 28261317 Free PMC article. Review.
-
Anti-cancer activity of guggulsterone by modulating apoptotic markers: a systematic review and meta-analysis.Front Pharmacol. 2023 May 2;14:1155163. doi: 10.3389/fphar.2023.1155163. eCollection 2023. Front Pharmacol. 2023. PMID: 37201024 Free PMC article.
-
Bile acids: regulation of synthesis.J Lipid Res. 2009 Oct;50(10):1955-66. doi: 10.1194/jlr.R900010-JLR200. Epub 2009 Apr 3. J Lipid Res. 2009. PMID: 19346330 Free PMC article. Review.
-
Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump.J Lipid Res. 2012 Mar;53(3):529-539. doi: 10.1194/jlr.M014688. Epub 2012 Jan 14. J Lipid Res. 2012. PMID: 22246918 Free PMC article.
-
Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.Front Pharmacol. 2018 Aug 6;9:686. doi: 10.3389/fphar.2018.00686. eCollection 2018. Front Pharmacol. 2018. PMID: 30127736 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources